Progyny, Inc. Shareholders' Equity
Progyny, Inc. (PGNY) had Shareholders' Equity of $453.26 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-07
- 2026-06-30: Stockholders' Equity Attributable to Parent $453.26M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $439.34M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $516.04M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $560.00M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $453.26M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $439.34M 10-Q · filed 2026-08-07 | |
| 2025-12-31 | $516.04M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $560.00M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $515.02M 10-Q · filed 2026-08-07 | |
| 2025-03-31 | $467.16M 10-Q · filed 2026-08-07 | |
| 2024-12-31 | $422.06M 10-Q · filed 2026-08-07 | |
| 2024-09-30 | $434.88M 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $456.19M 10-Q · filed 2025-11-07 | |
| 2024-03-31 | $571.60M 10-Q · filed 2025-08-08 | |
| 2023-12-31 | $553.43M 10-K · filed 2026-02-27 | |
| 2023-09-30 | $515.39M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $469.50M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $424.40M 10-Q · filed 2024-08-07 | |
| 2022-12-31 | $376.97M 10-K · filed 2026-02-27 | |
| 2022-09-30 | $346.86M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $311.02M 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $279.62M 10-Q · filed 2023-08-04 | |
| 2021-12-31 | $251.82M 10-K · filed 2025-03-03 | |
| 2021-09-30 | $224.11M 10-Q · filed 2022-11-04 | |
| 2021-06-30 | $204.54M 10-Q · filed 2022-11-04 | |
| 2021-03-31 | $184.62M 10-Q · filed 2022-08-05 | |
| 2020-12-31 | $166.95M 10-K · filed 2024-02-29 | |
| 2020-09-30 | $125.89M 10-Q · filed 2021-11-08 | $127.27M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $118.71M 10-Q · filed 2021-11-08 | $119.56M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $119.49M 10-Q · filed 2021-08-06 | $121.09M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $114.27M 10-K · filed 2023-03-01 | |
| 2019-09-30 | -$91.25M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | -$89.51M 10-Q · filed 2020-11-06 | |
| 2019-03-31 | -$92.08M 10-Q · filed 2020-08-07 | |
| 2018-12-31 | -$95.11M 10-K · filed 2022-03-01 | |
| 2018-09-30 | -$94.30M 10-Q · filed 2019-12-06 | |
| 2018-06-30 | -$92.80M 10-Q · filed 2019-12-06 | |
| 2017-12-31 | -$97.62M 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |